Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 7 of 7 clinical reviews.
A clinical review of David Sinclair's publicly confirmed use of NMN, metformin, and resveratrol for longevity, with peer-reviewed context on each compound's mechanisms and evidence base.
Read clinical reviewHow David Sinclair's confirmed NMN, metformin, and resveratrol regimen compares to other public longevity advocates, with clinical context from the HealthRX Medical Team.
Read clinical reviewHarvard longevity researcher David Sinclair has publicly confirmed taking NMN, metformin, and resveratrol for years. The HealthRX Medical Team examines what clinical evidence says about stopping or continuing these compounds long-term.
Read clinical reviewHarvard geneticist David Sinclair has openly shared his NMN, metformin, and resveratrol regimen. The HealthRX Medical Team maps his reported side effects against peer-reviewed clinical data.
Read clinical reviewHarvard geneticist David Sinclair has publicly detailed his use of NMN, metformin, and resveratrol for longevity. The HealthRX Medical Team breaks down what his regimen means for non-celebrity patients.
Read clinical reviewA clinical and financial breakdown of the NMN, metformin, and resveratrol regimen David Sinclair has publicly confirmed taking, with real-world cost and access data for everyday patients.
Read clinical reviewHarvard longevity scientist David Sinclair has publicly confirmed taking NMN, metformin, and resveratrol. We translate that public record into real clinical context: mechanisms, dosing, evidence, and the honest gaps in what we actually know.
Read clinical review